Cityblock raised $116M Series E and acquired Homeward Health to expand Medicare Advantage services, as digital health sees ...
GSK to spend $110M upfront licensing Hutchmed's KRAS-EGFR cancer drug HMPL-A830, up to $1.295B total, pending antitrust ...
Akeso, Summit say ivonescimab hit the OS bar in China's Phase 3 HARMONi-2 trial vs. Keytruda; full data due at a future ...
Pfizer gives Medicus Pharma co-development rights to ADC PF-08046031 for $12M upfront; Novartis consolidating Basel biologics ...
Merck's business development chief Sunil Patel says the drugmaker wants more deals as it diversifies beyond Keytruda ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results